Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib

PHASE2CompletedINTERVENTIONAL
Enrollment

387

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

April 30, 2008

Conditions
Chronic Myeloid LeukemiaPhiladelphia-Positive Myeloid Leukemia
Interventions
DRUG

Dasatinib

Tablets; oral; 70 mg BID, depending on response

Trial Locations (85)

Unknown

Local Institution, Anaheim

Local Institution, Loma Linda

Local Institution, Los Angeles

Local Institution, Stanford

Local Institution, Vallejo

Local Institution, Hartford

Local Institution, Washington D.C.

Local Institution, Jacksonville

Local Institution, Tampa

Local Institution, Atlanta

Local Institution, Chicago

Local Institution, Indianapolis

Local Institution, Kansas City

Local Institution, Baltimore

Local Institution, Boston

Local Institution, Detroit

Local Institution, Kansas City

Local Institution, St Louis

Local Institution, Omaha

Local Institution, Hackensack

Local Institution, New Brunswick

Local Institution, New York

Local Institution, Portland

Local Institution, Philadelphia

Local Institution, Pittsburgh

Local Institution, Greenville

Local Institution, Nashville

Local Institution, Dallas

Local Institution, Houston

Local Institution, San Antonio

Local Institution, Tyler

Local Institution, Spokane

Local Institution, St Leonards

Local Institution, South Brisbane

Local Institution, Adelaide

Local Institution, East Mebourne

Local Institution, Parkville

Local Institution, Wein

Local Institution, B-Leuven

Local Institution, Brussels

Local Institution, Edegem

Local Institution, Yvoir

Local Institution, Vancouver

Local Institution, Toronto

Local Institution, Montreal

Local Institution, Aarhus

Local Institution, Helsinki

Local Institution, Lille

Local Institution, Lyon

Local Institution, Nantes

Local Institution, Paris

Local Institution, Pessac

Local Institution, Poitiers

Local Institution, Strasbourg

Local Institution, Hamburg

Local Institution, Leipzig

Local Institution, Mainz

Local Institution, Mannheim

Local Institution, Co Galway

Local Institution, Dublin

Local Institution, Ramat Gan

Local Institution, Bari

Local Institution, Bologna

Local Institution, Milan

Local Institution, Napoli

Local Institution, Orbassano

Local Institution, Roma

Local Institution, Nijmegen

Local Institution, Rotterdam

Local Institution, Trondheim

Local Institution, Lima

Local Institution, Singapore

Local Institution, Parktown

Local Institution, Soweto

Local Institution, Kyunggi-Do

Local Institution, Barcelona

Local Institution, Madrid

Local Institution, Gothenburg

Local Institution, Lund

Local Institution, Stockholm

Local Institution, Umeå

Local Institution, Uppsala

Local Instituion, Basel

Local Institution, Glasgow

Local Institution, London

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY